Harnessing the power of digital and social media to maximize the doctor/patient relationship

Whether or not Obamacare survives in court, the cost-control squeeze is going to intensify

A tidal wave of information is on the horizon. Processing, analyzing and drawing accurate conclusions from that information is healthcare's next major challenge.

Pharmaceutical companies have not moved nearly fast enough to keep up with their customers' digital preferences

More than enough has been written how change is affecting our industry today. Instead, let's look at what hasn't changed and why the things that have not changed remain important.

A lot of ink has been spilt on the decline of the blockbuster and the search for a new specialty-product commercial model. But less attention has been paid to how that changes marketing strategy.

While doctors and nurses remain the first choice for most people with health concerns, the internet is making a significant impact on patients' healthcare decisions.

Many individuals outside the pharma industry have a maniacal vision of our senior executives.

It will take some time before we begin to see top-line results from the 2010 US Census. However, it's a pretty safe prediction that the new census will show us that we are at or near the point where more than one out of every three of the more than 300 million Americans did not designate themselves as white.

On Feb. 28, more than 30 countries across the world observed Rare Disease Day.